Supplier of veterinary medicines Animalcare has announced that it has traded in line with market expectations for the year.
The year has seen continued growth, with revenues 11 per cent ahead of the previous 12 months. Latest market statistics show sales of veterinary medicines for companion animals in the UK to be flat but Animalcare’s growth is well ahead of the general market.
The performance of the company’s core Licensed Veterinary Medicines group was particularly notable, with revenues up by 22 per cent compared with the previous year and the new product pipeline of licensed veterinary medicines continued to deliver.
Earlier this year, the company completed its relocation to new premises in the York area and the Group remains firmly on track with its stated strategy of investing in intellectual property protected products and services that will deliver future sustainable growth.